Currax Pharmaceuticals

Titan Pharmaceuticals is a biopharmaceutical company focused on the development and commercialization of treatments for central nervous system disorders, cardiovascular disease, bone disease and other disorders. Titan's products in development utilize technologies that have the potential to significantly improve the treatment of these diseases. Titan also establishes partnerships with government institutions and other leading pharmaceutical development companies. Titan Pharmaceuticals is headquartered in San Francisco.

SIGA Technologies applies microbial genomics to the design and development of novel products that prevent and treat infectious diseases, as well as defend against biological warfare agents. With technology platforms in both vaccines and antibiotics, the company s platform technologies include a vaccine delivery system that activates the immune system at the body s mucosal surfaces in order to prevent infection at the earliest possible stage, a surface protein expression system for the cost-effective production of proteins, biothreat rapid response therapeutics that can be rapidly designed on demand for any biological pathogen and virus counterstrike capability technology that can be used to develop safe and effective antivirals by targeting the proteinases which are encoded within all viruses. SIGA Technologies is headquartered in New York.

MeiraGTx is a clinical-stage genetic medicine company based in New York that is dedicated to unlocking the potential of genetic therapies for both rare and prevalent diseases. The company employs pioneering technologies, including a unique riboswitch gene regulation platform, to achieve precision control of gene expression, which can transform the treatment landscape for various disorders. With a commitment to improving patient lives, MeiraGTx integrates advanced science and an extensive manufacturing ecosystem to provide tailored treatments. Their diverse clinical pipeline reflects the company's focus on addressing inherited and non-inherited diseases through innovative approaches to genetic medicine. Generated from the website